1. Home
  2. BHC vs NVST Comparison

BHC vs NVST Comparison

Compare BHC & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHC
  • NVST
  • Stock Information
  • Founded
  • BHC N/A
  • NVST 2018
  • Country
  • BHC Canada
  • NVST United States
  • Employees
  • BHC N/A
  • NVST N/A
  • Industry
  • BHC Biotechnology: Pharmaceutical Preparations
  • NVST Medical/Dental Instruments
  • Sector
  • BHC Health Care
  • NVST Health Care
  • Exchange
  • BHC Nasdaq
  • NVST Nasdaq
  • Market Cap
  • BHC 3.0B
  • NVST 3.3B
  • IPO Year
  • BHC N/A
  • NVST 2019
  • Fundamental
  • Price
  • BHC $7.43
  • NVST $18.70
  • Analyst Decision
  • BHC Hold
  • NVST Hold
  • Analyst Count
  • BHC 4
  • NVST 14
  • Target Price
  • BHC $7.25
  • NVST $20.79
  • AVG Volume (30 Days)
  • BHC 1.4M
  • NVST 2.2M
  • Earning Date
  • BHC 10-30-2024
  • NVST 02-05-2025
  • Dividend Yield
  • BHC N/A
  • NVST N/A
  • EPS Growth
  • BHC N/A
  • NVST N/A
  • EPS
  • BHC N/A
  • NVST N/A
  • Revenue
  • BHC $9,474,000,000.00
  • NVST $2,503,300,000.00
  • Revenue This Year
  • BHC $10.68
  • NVST N/A
  • Revenue Next Year
  • BHC $3.66
  • NVST $2.94
  • P/E Ratio
  • BHC N/A
  • NVST N/A
  • Revenue Growth
  • BHC 10.91
  • NVST N/A
  • 52 Week Low
  • BHC $3.96
  • NVST $15.15
  • 52 Week High
  • BHC $11.46
  • NVST $25.64
  • Technical
  • Relative Strength Index (RSI)
  • BHC 37.99
  • NVST 38.26
  • Support Level
  • BHC $7.42
  • NVST $17.70
  • Resistance Level
  • BHC $7.79
  • NVST $20.86
  • Average True Range (ATR)
  • BHC 0.28
  • NVST 0.82
  • MACD
  • BHC -0.06
  • NVST -0.31
  • Stochastic Oscillator
  • BHC 8.40
  • NVST 21.46

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

About NVST Envista Holdings Corporation

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Share on Social Networks: